Read the latest news about type 1 diabetes advocacy and meet the people making a difference.
In 2007, there were only 28 people in Mali under the age of 25 with diabetes. It wasn’t that type 1 diabetes (T1D) didn’t exist in the African nation—rather the condition wasn’t being diagnosed or treated sufficiently, causing countless lives to be lost.
Two friends founded the charity in 2015 after realising the silent suffering of people in Southeast Asia. Many people with Type 1 Diabetes (T1D) in the region had no or very limited access to life-saving treatment and were not surviving. The organisation began supporting 15 young people in Myanmar and has since expanded to now have nearly 600 in their care across Southeast Asia.
A collaborative advocacy campaign of five diabetes organizations resulted in a significant investment of more than $300 million over 4 years from the Australian Federal Government. The cost of CGM including consumables (sensors) is around $5,000 per year, which is now fully subsidized for all Australians with type 1 diabetes.
Thanks to recent advances, people with type 1 diabetes (T1D) could potentially be freed from their blood-glucose monitors and insulin injections for years, or even decades.